Patent intelligence · US
US 8044093
Pharmaceutical compositions comprising docetaxel and methods for preparation thereof
Pharmaceutical compositions comprising docetaxel and methods for preparation thereof
Patent details — US 8044093
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 25, 2011
- Expiration
- Oct 20, 2031
- Claims
- 22
- CPC classes
- A61K, A61K31/337, A61K47/26, A61K9/0019
Quick answer
US 8044093 (Pharmaceutical compositions comprising docetaxel and methods for preparation thereof) is held by Beijing Century Biocom Pharmaceutical Technology Co., Ltd.. Status: granted. Granted Oct 25, 2011. Expires Oct 20, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 22
- CPC classes
- A61K, A61K31/337, A61K47/26, A61K9/0019, A61K9/08, A61K9/19
More from Beijing Century Biocom Pharmaceutical Technology Co., Ltd.
Related pharmaceutical patents in our USPTO index.
-
US 12274710
Compound for regulating body weight imbalance, composition thereof and application thereof
granted -
US 12269888
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
granted -
US 12194049
Composition for treating carbapenem antibiotic-resistant Acinetobacter baumannii infection
granted -
US 12084670
Regulating alkaloids
granted -
US 11883432
Chimeric antigen receptor system with adaptable receptor specificity
granted -
US 11865155
Plant extract obtained from Morus plant leaves which has an IC50 value to inhibit a-glucosidase I at a concentration of less than 90 uG/ml, compositions containing same, method of extraction and uses thereof
granted -
US 11667924
Increasing levels of nicotinic alkaloids in plants
granted -
US 11661459
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
granted
Related coverage
Frequently asked questions
What is US patent 8044093?
US 8044093 (Pharmaceutical compositions comprising docetaxel and methods for preparation thereof) is held by Beijing Century Biocom Pharmaceutical Technology Co., Ltd.. Status: granted. Granted Oct 25, 2011. Expires Oct 20, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8044093?
Beijing Century Biocom Pharmaceutical Technology Co., Ltd. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 39 pharmaceutical patents for this assignee.
When does US 8044093 expire?
Our index shows an expiration date of Oct 20, 2031 (5 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.